Pharmaceuticals

Global Immunohematology Market Size Projected to Reach $3.17 Billion During the Forecast Period

November 9, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Immunohematology Market Expected To Expand Between 2025 And 2029?

The immunohematology market has shown consistent expansion over recent years. It is anticipated to increase from $2.46 billion in 2024 to $2.55 billion in 2025, progressing at a compound annual growth rate (CAGR) of 3.6%. This historical development can be ascribed to progress in blood transfusion science, the common occurrence of blood disorders, the growth of blood banks, governmental initiatives for ensuring blood safety, a rise in surgical procedures, and greater understanding of risks tied to transfusions.

The immunohematology market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $3.17 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.7%. This growth during the projection period stems from factors such as a rising need for point-of-care diagnostics, the introduction of new blood products, advancements in healthcare facilities, genetic assessments for blood matching, and governmental backing for ensuring blood safety. Key developments expected in the forecast timeframe encompass automation coupled with high-throughput capabilities, molecular techniques for blood typing, advancements in antibody identification, comprehensive patient blood management initiatives, the incorporation of AI into analytical processes, and the widespread adoption of telemedicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Which Drivers Are Impacting The Immunohematology Market?

The rising occurrence of hematological disorders is anticipated to spur the growth of the immunohematology market. Hematological disorders are a broad category of conditions that affect the blood, including its vital components such as red blood cells, white blood cells, platelets, and plasma. Immunohematology is crucial for safe and efficient blood transfusions, preventing reactions caused by incompatible blood types or the presence of antibodies in the recipient. Additionally, immunohematology techniques are utilized to diagnose and manage diseases of the immune system that may impact the hematological system. For instance, data from Cancer Research UK, a UK-based research organization, indicates that the average annual number of new leukemia cases attributed to hematological disorders in the UK is projected to rise from approximately 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Thus, the increasing incidence of hematological disorders is a key driver for the expansion of the immunohematology market.

What Are The Major Segments Identified In The Immunohematology Market?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Are The Latest Industry Trends Transforming The Immunohematology Market?

Leading companies in the immunohematology market are concentrating on creating advanced diagnostic solutions, which include soluble recombinant proteins aimed at counteracting the interference from the cancer therapy daratumumab. A soluble recombinant protein is one generated via recombinant DNA technology that maintains its proper folding and function in a soluble state within a host cell or solution, thereby simplifying its application in research and therapeutic contexts. For instance, in November 2023, Grifols, S.A., a pharmaceutical firm based in Spain, launched the Grifols sCD38 solution. Grifols’ sCD38 stands as the inaugural soluble recombinant protein, developed to address the interference caused by the cancer therapy daratumumab during essential blood transfusion compatibility testing. This innovative solution, specifically designed for multiple myeloma patients, prevents daratumumab from attaching to CD38 proteins on red blood cells, thus ensuring precise pre-transfusion test outcomes. By enabling a more streamlined process for screening, identification, and crossmatching, Grifols sCD38 improves blood transfusion protocols and minimizes delays in delivering lifesaving transfusions.

Which Key Players Are Driving Competition In The Immunohematology Market?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Currently Holds The Largest Share Of The Immunohematology Market?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Immunohematology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

Browse Through More Reports Similar to the Global Immunohematology Market 2025, By The Business Research Company

Out Of Home Advertising Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/out-of-home-advertising-global-market-report

Print Advertising Distribution Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/print-advertising-distribution-global-market-report

Print Advertising Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/print-advertising-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795